Grantham Mayo Van Otterloo & Co. LLC Increases Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Grantham Mayo Van Otterloo & Co. LLC increased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 1.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 451,607 shares of the company's stock after purchasing an additional 7,386 shares during the period. Grantham Mayo Van Otterloo & Co. LLC owned approximately 0.10% of GE HealthCare Technologies worth $35,307,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. CoreFirst Bank & Trust purchased a new stake in shares of GE HealthCare Technologies during the fourth quarter valued at approximately $25,000. Runnymede Capital Advisors Inc. bought a new position in GE HealthCare Technologies in the 4th quarter valued at approximately $28,000. Continuum Advisory LLC boosted its stake in GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company's stock valued at $31,000 after purchasing an additional 168 shares during the last quarter. Bank of Jackson Hole Trust bought a new stake in shares of GE HealthCare Technologies in the 4th quarter worth $32,000. Finally, OFI Invest Asset Management purchased a new position in shares of GE HealthCare Technologies in the fourth quarter worth $34,000. 82.06% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts have recently commented on GEHC shares. Citigroup lifted their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research note on Thursday, February 13th. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and increased their price target for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Wells Fargo & Company upped their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a report on Friday, February 14th. Finally, The Goldman Sachs Group upgraded GE HealthCare Technologies from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $85.00 to $100.00 in a research report on Tuesday, March 11th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $97.73.

GE HealthCare Technologies Trading Down 0.0 %

GE HealthCare Technologies stock traded down $0.03 during mid-day trading on Friday, hitting $62.26. The company's stock had a trading volume of 2,660,224 shares, compared to its average volume of 3,105,913. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The stock has a market cap of $28.47 billion, a PE ratio of 14.33, a P/E/G ratio of 3.19 and a beta of 1.14. The company has a 50 day moving average of $82.23 and a 200-day moving average of $84.27. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping the consensus estimate of $1.26 by $0.19. The company had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. On average, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be paid a $0.035 dividend. The ex-dividend date of this dividend is Friday, April 25th. This represents a $0.14 annualized dividend and a yield of 0.22%. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 3.23%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.